Hui Han

2.3k total citations
110 papers, 1.3k citations indexed

About

Hui Han is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Hui Han has authored 110 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Surgery, 41 papers in Pulmonary and Respiratory Medicine and 25 papers in Rheumatology. Recurrent topics in Hui Han's work include Genital Health and Disease (40 papers), Renal cell carcinoma treatment (24 papers) and Urologic and reproductive health conditions (23 papers). Hui Han is often cited by papers focused on Genital Health and Disease (40 papers), Renal cell carcinoma treatment (24 papers) and Urologic and reproductive health conditions (23 papers). Hui Han collaborates with scholars based in China, United States and Hong Kong. Hui Han's co-authors include Kai Yao, Zhuowei Liu, Fangjian Zhou, Shengjie Guo, Zi-Ke Qin, Zike Qin, Frank Yonghong Li, Fang-Jian Zhou, Pei Dong and Zhiling Zhang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Hui Han

97 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Han China 20 602 375 370 304 298 110 1.3k
Daniel Kedar Israel 20 555 0.9× 125 0.3× 414 1.1× 337 1.1× 399 1.3× 54 1.4k
Kai Yao China 21 713 1.2× 310 0.8× 324 0.9× 266 0.9× 289 1.0× 89 1.2k
Tomoyasu Tsushima Japan 25 673 1.1× 92 0.2× 489 1.3× 304 1.0× 700 2.3× 101 1.6k
Jun Miki Japan 19 508 0.8× 84 0.2× 457 1.2× 559 1.8× 630 2.1× 171 1.6k
Heiko Wunderlich Germany 24 415 0.7× 91 0.2× 871 2.4× 275 0.9× 724 2.4× 91 1.6k
Taketo Kawai Japan 17 403 0.7× 94 0.3× 139 0.4× 272 0.9× 239 0.8× 98 834
Teodoro Sava Italy 18 282 0.5× 87 0.2× 292 0.8× 502 1.7× 554 1.9× 69 1.1k
Sam D. Graham United States 20 342 0.6× 212 0.6× 280 0.8× 297 1.0× 715 2.4× 49 1.3k
Eric Kauffman United States 19 594 1.0× 50 0.1× 730 2.0× 256 0.8× 722 2.4× 76 1.7k
Martti Ala‐Opas Finland 26 360 0.6× 110 0.3× 465 1.3× 438 1.4× 894 3.0× 63 1.6k

Countries citing papers authored by Hui Han

Since Specialization
Citations

This map shows the geographic impact of Hui Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Han more than expected).

Fields of papers citing papers by Hui Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Han. The network helps show where Hui Han may publish in the future.

Co-authorship network of co-authors of Hui Han

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Han. A scholar is included among the top collaborators of Hui Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Han. Hui Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Jianbin, Haixia Jia, & Hui Han. (2025). Emerging drivers of female bladder cancer: a pathway to precision prevention and treatment. Frontiers in Oncology. 15. 1497637–1497637.
3.
4.
Wang, Yanjun, Zhiming Wu, Shengjie Guo, et al.. (2024). Regional lymph node mapping in patients with penile cancer undergoing radical inguinal lymph node dissection – a retrospective cohort study. International Journal of Surgery. 110(5). 2865–2873. 2 indexed citations
5.
Chen, Lingxiao, et al.. (2024). Advances in molecular basis of response to immunotherapy for penile cancer: better screening of responders. Frontiers in Oncology. 14. 1394260–1394260. 2 indexed citations
6.
Shu, Guannan, Xuanxuan Lu, Yihui Pan, et al.. (2023). Exosomal circSPIRE1 mediates glycosylation of E-cadherin to suppress metastasis of renal cell carcinoma. Oncogene. 42(22). 1802–1820. 32 indexed citations
7.
8.
Huang, Kangbo, et al.. (2023). Human Papillomavirus Infection in Penile Cancer: Multidimensional Mechanisms and Vaccine Strategies. International Journal of Molecular Sciences. 24(23). 16808–16808. 3 indexed citations
9.
Dong, Pei, Yulu Peng, Ruiqi Liu, et al.. (2022). Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma. Clinical Cancer Research. 28(21). 4807–4819. 12 indexed citations
10.
Wang, Yanjun, Hui Han, Zike Qin, et al.. (2022). RAB20 Promotes Proliferation via G2/M Phase through the Chk1/cdc25c/cdc2-cyclinB1 Pathway in Penile Squamous Cell Carcinoma. Cancers. 14(5). 1106–1106. 5 indexed citations
11.
Pan, Yihui, Xuanxuan Lu, Guannan Shu, et al.. (2022). Extracellular Vesicle-Mediated Transfer of LncRNA IGFL2-AS1 Confers Sunitinib Resistance in Renal Cell Carcinoma. Cancer Research. 83(1). 103–116. 58 indexed citations
12.
Liu, Yang, Xinyue Zhang, Li Tian, et al.. (2022). Locoregional recurrence after nephrectomy for localized renal cell carcinoma: Feasibility and outcomes of different treatment modalities. Cancer Medicine. 11(23). 4430–4439. 6 indexed citations
13.
Li, Yilin, Rongliang Zheng, Yijun Zhang, et al.. (2022). Special issue “The advance of solid tumor research in China”: 68Ga‐PSMA‐11 PET/CT for evaluating primary and metastatic lesions in different histological subtypes of renal cell carcinoma. International Journal of Cancer. 152(1). 42–50. 17 indexed citations
14.
Liu, Yang, Zhiling Zhang, Zitong Zhang, et al.. (2021). Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy. World Journal of Urology. 39(11). 4183–4190. 19 indexed citations
15.
Liu, Yang, Zhiling Zhang, Ruiqi Liu, et al.. (2021). Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma. Radiation Oncology. 16(1). 211–211. 12 indexed citations
16.
Huang, Kangbo, Yihui Pan, Guannan Shu, et al.. (2021). Circular RNA circSNX6 promotes sunitinib resistance in renal cell carcinoma through the miR-1184/GPCPD1/ lysophosphatidic acid axis. Cancer Letters. 523. 121–134. 33 indexed citations
17.
18.
Chen, Mingkun, Yunlin Ye, Baojia Zou, et al.. (2016). C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation. Journal of Translational Medicine. 14(1). 55–55. 10 indexed citations
19.
Yao, Kai, Hyewon Youn, Xiaoyan Gao, et al.. (2012). Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells. The Prostate. 72(13). 1423–1430. 23 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Kedar Breakdown of academic impact, for papers by Kai Yao Breakdown of academic impact, for papers by Tomoyasu Tsushima Breakdown of academic impact, for papers by Jun Miki Breakdown of academic impact, for papers by Heiko Wunderlich Breakdown of academic impact, for papers by Taketo Kawai Breakdown of academic impact, for papers by Teodoro Sava Breakdown of academic impact, for papers by Sam D. Graham Breakdown of academic impact, for papers by Eric Kauffman Breakdown of academic impact, for papers by Martti Ala‐Opas
Rankless by CCL
2026